- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 171573, 6 pages
Allicin Attenuates Inflammation and Suppresses HLA-B27 Protein Expression in Ankylosing Spondylitis Mice
1Department of Orthopaedics, Shanghai Tenth People’s Hospital Affiliated to TongJi University, Shanghai 20072, China
2Department of Orthopaedics, The Second Affiliated Hospital of the Second Military Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China
Received 21 March 2013; Revised 18 September 2013; Accepted 18 September 2013
Academic Editor: Kazim Husain
Copyright © 2013 Xin Gu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Burgos-Vargas, J. Vázquez-Mellado, N. Cassis et al., “Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria,” The Journal of Rheumatology, vol. 23, no. 12, pp. 2140–2147, 1996.
- A. Calin, S. Brophy, and D. Blake, “Impact of sex on inheritance of ankylosing spondylitis: a cohort study,” The Lancet, vol. 354, no. 9191, pp. 1687–1690, 1999.
- D. A. Brewerton, F. D. Hart, A. Nicholls, M. Caffrey, D. C. James, and R. D. Sturrock, “Ankylosing spondylitis and HL-A 27,” The Lancet, vol. 301, no. 7809, pp. 904–907, 1973.
- J. Londono, M. C. Romero-Sanchez, V. G. Torres, et al., “The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis,” Revista Brasileira de Reumatologia, vol. 52, no. 4, pp. 536–544, 2012.
- L. Zeng, M. J. Lindstrom, and J. A. Smith, “Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response,” Arthritis & Rheumatism, vol. 63, no. 12, pp. 3807–3817, 2011.
- C. J. Cavallito, J. S. Buck, and C. M. Suter, “Allicin, the antibacterial principle of Allium sativum. II. Determination of the chemical structure,” Journal of the American Chemical Society, vol. 66, no. 11, pp. 1952–1954, 1944.
- A. Lang, M. Lahav, E. Sakhnini et al., “Allicin inhibits spontaneous and TNF-α induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells,” Clinical Nutrition, vol. 23, no. 5, pp. 1199–1208, 2004.
- K. T. Augusti and P. T. Mathew, “Lipid lowering effect ollicin (diallyl disulphide oxide) on long term feeding to normal rats,” Experientia, vol. 30, no. 5, pp. 468–470, 1974.
- Y. Lu, Z. He, X. Shen, et al., “Cholesterol-lowering effect of allicin on hypercholesterolemic ICR mice,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 489690, 6 pages, 2012.
- M. F. Melzig, E. Krause, and S. Franke, “Inhibition of adenosine deaminase activity of aortic endothelial cells by extracts of garlic (Allium sativum L.),” Die Pharmazie, vol. 50, no. 5, pp. 359–361, 1995.
- K. Prasad, V. A. Laxdal, M. Yu, and B. L. Raney, “Antioxidant activity of allicin, an active principle in garlic,” Molecular and Cellular Biochemistry, vol. 148, no. 2, pp. 183–189, 1995.
- C. Liu, F. Cao, Q.-Z. Tang et al., “Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways,” Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1238–1250, 2010.
- Z. M. Ross, E. A. O'Gara, D. J. Hill, H. V. Sleightholme, and D. J. Maslin, “Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder,” Applied and Environmental Microbiology, vol. 67, no. 1, pp. 475–480, 2001.
- S. Ankri and D. Mirelman, “Antimicrobial properties of allicin from garlic,” Microbes and Infection, vol. 1, no. 2, pp. 125–129, 1999.
- M. J. Turner, M. L. DeLay, S. Bai, E. Klenk, and R. A. Colbert, “HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease,” Arthritis & Rheumatism, vol. 56, no. 1, pp. 215–223, 2007.
- X. H. Li, C. -Y Li, Z.-G. Xiang, et al., “Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways,” Cardiovascular Drugs and Therapy, vol. 26, no. 6, pp. 457–465, 2012.
- Z. Li Yongsheng, “Effect of RNAi-mediated gene silencing of HER2 /neu on proliferation and apoptosis in bladder cancer cell line BIU-87,” Journal of Third Military Medical University, vol. 34, no. 1, pp. 20–23, 2012.
- Y. Feng, X. Zhu, Q. Wang, et al., “Allicin enhances host pro-inflammatory immune responses and protects against acute murine malaria infection,” Malaria Journal, vol. 11, no. 1, p. 268, 2012.
- N. Ota, F. Takano, S. Muroga et al., “Garlic extract and its selected organosulphur constituents promote ileal immune responses ex vivo,” Journal of Functional Foods, vol. 4, no. 1, pp. 243–252, 2012.
- S. H. Murch, C. P. Braegger, J. A. Walker-Smith, and T. T. MacDonald, “Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease,” Gut, vol. 34, no. 12, pp. 1705–1709, 1993.
- A. M. Williams, C. V. Whiting, K. Bonhagen et al., “Tumour necrosis factor-alpha (TNF-α) transcription and translation in the CD4+ T cell-transplanted scid mouse model of colitis,” Clinical and Experimental Immunology, vol. 116, no. 3, pp. 415–424, 1999.
- O. Dienz and M. Rincon, “The effects of IL-6 on CD4 T cell responses,” Clinical Immunology, vol. 130, no. 1, pp. 27–33, 2009.
- G. Zhang, J. Luo, J. Bruckel et al., “Genetic studies in familial ankylosing spondylitis susceptibility,” Arthritis & Rheumatism, vol. 50, no. 7, pp. 2246–2254, 2004.
- L.-S. Tam, J. Gu, and D. Yu, “Pathogenesis of ankylosing spondylitis,” Nature Reviews Rheumatology, vol. 6, no. 7, pp. 399–405, 2010.
- N. S. Dangoria, M. L. Delay, D. J. Kingsbury et al., “HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum,” Journal of Biological Chemistry, vol. 277, no. 26, pp. 23459–23468, 2002.
- S. Kollnberger, L. A. Bird, M. Roddis et al., “HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors,” The Journal of Immunology, vol. 173, no. 3, pp. 1699–1710, 2004.
- T. M. Tran, N. Satumtira, M. L. Dorris et al., “HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP,” The Journal of Immunology, vol. 172, no. 8, pp. 5110–5119, 2004.
- A. Taylan, I. Sari, B. Akinci, et al., “Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis,” BMC Musculoskeletal Disorders, vol. 13, no. 1, p. 191, 2012.
- J. C. C. Wei, K. S. Hung, Y. W. Hsu, et al., “Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients,” PloS ONE, vol. 7, no. 12, Article ID e49698, 2012.